Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Z. Yu. Mutovina"'
Autor:
E. N. Misyurina, E. A. Baryakh, N. F. Frolova, O. N. Kotenko, Z. Yu. Mutovina, S. S. Andreev, T. N. Tolstykh, K. V. Yatskov, E. A. Karimova, A. B. Makeshova, O. A. Rukavitsyn, A. V. Misyurin, Yu. Yu. Polyakov, M. A. Mingalimov, T. S. Chudnova, D. E. Gagloeva, D. D. Ivanova, A. I. Koneva, O. L. Kochneva, E. N. Zotina, E. Yu. Grishina, L. T. Shimanovskaya, V. N. Yakimets, E. I. Zhelnova
Publikováno v:
Онкогематология, Vol 18, Iss 4, Pp 10-39 (2024)
In December 2019, cases of severe respiratory infection were reported in Wuhan, China. The disease was caused by a new, previously undescribed coronavirus, structurally similar to the then known SARS-CoV virus. The World Health Organization has named
Externí odkaz:
https://doaj.org/article/6c9982b78af94d8e92e3fb3b76bf0c82
Publikováno v:
Научно-практическая ревматология, Vol 60, Iss 4, Pp 495-500 (2022)
According to modern concepts, myocarditis is an inflammatory disease of the myocardium, diagnosed on the basis of generally accepted histological, immunological, immunohistochemical criteria. Previously, most researchers believed that the most common
Externí odkaz:
https://doaj.org/article/a7ae116e2e6f43f7b0d2c967ddd3629c
Autor:
А. I. Zagrebneva, Е. А. Baryakh, Е. I. Zhelnova, N. G. Poteshkina, I. Р. Beloglazova, Z. Yu. Mutovina, I. V. Samsonova, Е. А. Kovalevskaya, V. V. Parshin, V. V. Pshenichnikova, D S. Fomina, Т. S. Kruglova, М. А. Lysenko, М. А. Dranitsyna
Publikováno v:
Антибиотики и Химиотерапия, Vol 66, Iss 1-2, Pp 47-56 (2021)
The effects of baricitinib, a selective reversible inhibitor of Janus kinase 1 and 2, in the treatment of COVID-19 are associated with different aspects of pathogenesis — inhibition of viral endocytosis, reduction of excessive inflammatory respo
Externí odkaz:
https://doaj.org/article/8c61a3dab1a541eb8b65bcfed4de9455
Publikováno v:
Современная ревматология, Vol 13, Iss 3, Pp 82-86 (2019)
In 2008, the term cardiorenal syndrome (CRS) was proposed by the Acute Dialysis Quality Initiative (ADQI) Group to denote pathological reciprocal conditions involving the heart and kidneys, which develop due to acute or chronic dysfunction of one of
Externí odkaz:
https://doaj.org/article/dcec55bef71441f0821e20c127a6854f
Publikováno v:
Научно-практическая ревматология, Vol 53, Iss 4, Pp 343-445 (2015)
Systemic sclerosis (SS), is an autoimmune connective tissue disease, the main clinical signs of which are due to disseminated microcirculatory disorders and fibrosis of the skin and viscera. Morphological examinations showed that 80% of patients with
Externí odkaz:
https://doaj.org/article/b4c8ad4b7cfb4d3894e01e07824da98f
Autor:
M V, Putilina, Z Yu, Mutovina, O V, Kurushina, D M, Khalilova, E N, Saverskaya, S B, Stepanova, M A, Khoreva, A S, Starikov
Publikováno v:
Neuroscience and Behavioral Physiology. 52:836-841
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4625c974e2ce26b9f728690ee573c957
https://doi.org/10.1007/s11055-022-01307-2
https://doi.org/10.1007/s11055-022-01307-2
Publikováno v:
Терапевтический архив, Vol 87, Iss 5, Pp 84-89 (2015)
Hemophagocytic syndrome (HPS) is a rare life-threatening condition caused by massive cytokine release from activated macrophages and lymphocytes. The paper depicts the development of HPS in different infections, malignancies, and autoimmune diseases.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d35b0164b1427aa245efb6d87c2689a
https://ter-arkhiv.ru/0040-3660/article/view/31763
https://ter-arkhiv.ru/0040-3660/article/view/31763
Publikováno v:
Терапевтический архив, Vol 87, Iss 5, Pp 84-89 (2015)
Hemophagocytic syndrome (HPS) is a rare life-threatening condition caused by massive cytokine release from activated macrophages and lymphocytes. The paper depicts the development of HPS in different infections, malignancies, and autoimmune diseases.
Externí odkaz:
https://doaj.org/article/7fd1dae3f7c34dc1b107f789db395a00